Halozyme Therapeutics Welcomes David Ramsay as Interim CFO for Future Growth Halozyme Therapeutics has appointed David Ramsay as the Interim CFO, bringing extensive financial leadership and experience in biotech to the role.

Halozyme Therapeutics Welcomes David Ramsay as Interim CFO for Future Growth #United_States #San_Diego #CFO #Halozyme #David_Ramsay